The current coronavirus disease 2019 (COVID-19) pandemic has had a significant impact on our healthcare system. Still, very little is known about the treatment modalities in the context of severe COVID in pregnancy. We describe a case of a 28-year-old patient who presented with severe COVID-19 and was admitted to our intensive care unit (ICU) in her third-trimester pregnancy with a progressive increase in oxygen requirement. Remdesivir may prove beneficial in reducing the inflammatory response and controlling the direct viral damage due to severe COVID-19 pneumonia resulting in favorable maternal and fetal outcomes.
Ramy Abou Ghayda, Han Li, Keum Hwa Lee, Hee Won Lee, Sung Hwi Hong, Moonsu Kwak, Minwoo Lee, Minjae Kwon, Ai Koyanagi, Andreas Kronbichler, Louis Jacob, Lee Smith, Jae Il Shin
Yaseen M. Arabi, Élie Azoulay, Hasan M. Al‐Dorzi, Jason Phua, Jorge I. Salluh, Alexandra Binnie, Carol Hodgson, Derek C. Angus, Maurizio Cecconi, Bin Du, Rob Fowler, Charles D. Gomersall, Peter Horby, Nicole P. Juffermans, Jozef Kesecioğlu, Ruth Kleinpell, F.S. Machado, Greg S. Martin, Geert Meyfroidt, Andrew Rhodes, Kathy Rowan, Jean‐François Timsit, Jean Louis Vincent, Giuseppe Citerio
Discussion(0)
No comments yet. Be the first to comment.